| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Daphnilongeranin C; Daphnilongeranin C | CFN97231 | 750649-07-1 | C22H29NO3 = 355.5 | 5mg | QQ客服：215959384 |
| 7-Acetylscorpioidine; 7-Acetylscorpioidine | CFN00316 | 80405-17-0 | C22H33NO7 = 423.50 | 5mg | QQ客服：1413575084 |
| Anadoline N-oxide; Anadoline N-oxide | CFN00317 | 28513-29-3 | C20H31NO7 = 397.47 | 5mg | QQ客服：215959384 |
| Senampeline A; Senampeline A | CFN00318 | 62787-00-2 | C25H31NO8 = 473.52 | 5mg | QQ客服：1457312923 |
| Senampeline B; Senampeline B | CFN00319 | 62860-52-0 | C25H31NO8 = 473.52 | 5mg | QQ客服：2159513211 |
| Senampeline C; Senampeline C | CFN00320 | 62841-11-6 | C25H31NO8 = 473.52 | 5mg | QQ客服：215959384 |
| Senampeline D; Senampeline D | CFN00321 | 62787-01-3 | C25H31NO8 = 473.52 | 5mg | QQ客服：1413575084 |
| 倒千里光裂碱; Retronecine | CFN00322 | 480-85-3 | C8H13NO2 = 155.20 | 5mg | QQ客服：3257982914 |
| 倒千里光碱氮氧化物; Retronecine N-oxide | CFN00323 | 6870-33-3 | C8H13NO3 = 171.2 | 5mg | QQ客服：1413575084 |
| 7-当酰倒千里光碱; 7-Angeloylretronecine | CFN00324 | 6029-82-9 | C13H19NO3 = 237.30 | 5mg | QQ客服：215959384 |
| 9-当酰倒千里光碱氮氧化物; 9-Angeloylretronecine N-oxide | CFN00325 | 27773-86-0 | C13H19NO4 = 253.30 | 5mg | QQ客服：2159513211 |
| 溪岸千里光碱; Rivularine | CFN00326 | 723-78-4 | C13H19NO3 = 237.29 | 5mg | QQ客服：215959384 |
| 1,4-二氢-1-甲基-4-氧代-3-吡啶甲腈; Mallorepine | CFN97248 | 767-98-6 | C7H6N2O = 134.1 | 5mg | QQ客服：2159513211 |
| 阿茹明; Asperumine | CFN00327 | 78513-20-9 | C18H25NO4 = 319.40 | 5mg | QQ客服：2159513211 |
| Pyrrolam A; Pyrrolam A | CFN00328 | 126424-76-8 | C7H9NO = 123.15 | 5mg | QQ客服：2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)